新型糖皮质激素在炎症性肠病治疗中有效性和安全性的研究现状(英文)

被引:18
作者
艾佳
黄奇
缪应雷
机构
[1] 昆明医科大学第一附属医院消化内科
关键词
炎症性肠病; 溃疡性结肠炎; 克罗恩病; 系统激素; 糖皮质激素; 布地奈德; 倍氯米松;
D O I
暂无
中图分类号
R574.62 [结肠疾病];
学科分类号
100201 [内科学];
摘要
炎症性肠病包括溃疡性结肠炎和克罗恩病,全世界约有2 500 000人患有此病.其病因可能是基因易感人群对肠道菌群的免疫应答失调.传统糖皮质激素能有效诱导活动期疾病缓解,但同时伴有诸多全身副作用.新型糖皮质激素如布地奈德和倍氯米松,粘膜吸收、灭活迅速,起效快,抗炎作用强且全身副作用少.这些新型制剂口服后被小肠的吸收,特异地释放于肠道粘膜,发挥其强大的抗炎作用.就新型糖皮质激素在炎症性肠病治疗中的有效性和安全性做简要评估和总结.
引用
收藏
页码:167 / 173+180 +180
页数:8
相关论文
共 22 条
[1]
3g mesalazine granules are superior to 9mg budesonide for achieving remission in active ulcerative colitis: A double-blind; double-dummy; randomised trial.[J].Volker Gross;Ivan Bunganic;Elena A. Belousova;Tatyana L. Mikhailova;Limas Kupcinskas;Gediminas Kiudelis;Zsolt Tulassay;Libor Gabalec;Andrey E. Dorofeyev;Jelena Derova;Karin Dilger;Roland Greinwald;Ralph Mueller.Journal of Crohn's and Colitis.2010, 2
[2]
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management [J].
Dignass, A. ;
Van Assche, G. ;
Lindsay, J. O. ;
Lemann, M. ;
Soderholm, J. ;
Colombel, J. F. ;
Danese, S. ;
D'Hoore, A. ;
Gassull, M. ;
Gomollon, F. ;
Hommes, D. W. ;
Michetti, P. ;
O'Morain, C. ;
Oresland, T. ;
Windsor, A. ;
Stange, E. F. ;
Travis, S. P. L. .
JOURNAL OF CROHNS & COLITIS, 2010, 4 (01) :28-62
[3]
Beclomethasone dipropionate in Crohn's ileitis: A randomised; double-blind trial.[J].Cosimo Prantera;Marina Rizzi;Mario Cottone;Angelo Casa;Vito Annese;Giacomo Carlo Sturniolo;Stefano Marconi;Herbert Lochs.Digestive and Liver Disease.2010, 6
[4]
Oral Beclomethasone Dipropionate in Pediatric Active Ulcerative Colitis: A Comparison Trial With Mesalazine [J].
Romano, Claudio ;
Famiani, Annalisa ;
Comito, Donatella ;
Rossi, Paolo ;
Raffa, Vanessa ;
Fries, Walter .
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2010, 50 (04) :385-389
[5]
World Gastroenterology Organization Practice Guidelines for the Diagnosis and Management of IBD in 2010.[J].Charles N.Bernstein;MichaelFried;J.H.Krabshuis;HenryCohen;R.Eliakim;SuleimanFedail;RichardGearry;K.L.Goh;SaheedHamid;Aamir GhaforKhan;A.W.LeMair;Malfertheiner;QinOuyang;J.F.Rey;AjitSood;FlavioSteinwurz;Ole O.Thomsen;AlanThomson;GillianWatermeyer.Inflamm Bowel Dis.2009, 1
[6]
Oral Beclomethasone Dipropionate as an Alternative to Systemic Steroids in Mild to Moderate Ulcerative Colitis Not Responding to Aminosalicylates [J].
Papi, Claudio ;
Aratari, Annalisa ;
Moretti, Alessandra ;
Mangone, Manuela ;
Margagnoni, Giovanna ;
Koch, Maurizio ;
Capurso, Lucio .
DIGESTIVE DISEASES AND SCIENCES, 2010, 55 (07) :2002-2007
[8]
Direct Health Care Costs of Crohn's Disease and Ulcerative Colitis in US Children and Adults [J].
Kappelman, Michael D. ;
Rifas-Shiman, Sheryl L. ;
Porter, Carol Q. ;
Ollendorf, Daniel A. ;
Sandler, Robert S. ;
Galanko, Joseph A. ;
Finkelstein, Jonathan A. .
GASTROENTEROLOGY, 2008, 135 (06) :1907-1913
[9]
Efficacy and safety of oral beclomethasone dipropionate for ileal or ileal-right colon Crohn's disease of mild-to-moderate activity or in remission: Retrospective study [J].
Astegiano, M. ;
Pagano, N. ;
Sapone, N. ;
Simondi, D. ;
Bertolusso, L. ;
Bresso, F. ;
Demarchi, B. ;
Pellicano, R. ;
Bonardi, R. ;
Marconi, S. ;
Rizzetto, M. .
BIOMEDICINE & PHARMACOTHERAPY, 2007, 61 (06) :370-376
[10]
Meta-analysis: the efficacy of rectal beclomethasone dipropionate vs. 5-aminosalicylic acid in mild to moderate distal ulcerative colitis [J].
Manguso, F. ;
Balzano, A. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2007, 26 (01) :21-29